Show source-provided references
1. Riudavets, M., de Herreros, M.G., Besse, B., and Mezquita, L. (2022). Radon and lung cancer: Current trends and future perspectives. Cancers, 14.
10.3390/cancers14133142 ↗2. Co-delivery of doxorubicin and curcumin via cRGD-peptide modified PEG-PLA self-assembly nanomicelles for lung cancer therapy
10.1016/j.cclet.2021.11.076 ↗4. US National Cancer Institute (2022, October 11). Cancer Stat Facts: Lung and Bronchus Cancer, Available online: https://seer.cancer.gov/statfacts/html/lungb.html.
7. Advances in our understanding of the molecular mechanisms of action of cisplatin in cancer therapy
10.2147/JEP.S267383 ↗10. Curcumin: Updated molecular mechanisms and intervention targets in human lung cancer
10.3390/ijms13033959 ↗13. Yang, Z.-J., Huang, S.-Y., Zhou, D.-D., Xiong, R.-G., Zhao, C.-N., Fang, A.-P., Zhang, Y.-J., Li, H.-B., and Zhu, H.-L. (2022). Effects and mechanisms of curcumin for the prevention and management of cancers: An updated review. Antioxidants, 11.
10.3390/antiox11081481 ↗14. Effect of nano-curcumin on various diseases: A comprehensive review of clinical trials
10.1002/biof.1932 ↗16. Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and-9 and Vascular Endothelial Growth Factor (VEGF)
10.1016/j.canlet.2009.04.037 ↗17. Khan, F.B., Singh, P., Jamous, Y.F., Ali, S.A., Uddin, S., Zia, Q., Jena, M.K., Khan, M., Owais, M., and Huang, C.Y. (2023). Multifaceted Pharmacological Potentials of Curcumin, Genistein, and Tanshinone IIA through Proteomic Approaches: An In-Depth Review. Cancers, 15.
10.3390/cancers15010249 ↗18. Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects
10.1002/ptr.7305 ↗19. A difunctional Pluronic® 127-based in situ formed injectable thermogels as prolonged and controlled curcumin depot, fabrication, in vitro characterization and in vivo safety evaluation
10.1080/09205063.2020.1829324 ↗21. Tabanelli, R., Brogi, S., and Calderone, V. (2021). Improving curcumin bioavailability: Current strategies and future perspectives. Pharmaceutics, 13.
10.3390/pharmaceutics13101715 ↗29. Simultaneous determination of degree of deacetylation, degree of substitution and distribution fraction of–COONa in carboxymethyl chitosan by potentiometric titration
10.1016/j.carbpol.2011.12.019 ↗31. Multifunctional quercetin conjugated chitosan nano-micelles with P-gp inhibition and permeation enhancement of anticancer drug
10.1016/j.carbpol.2018.09.020 ↗32. Fabrication of Redox-and pH-Sensitive Self-Assembled Nano-Micelles with Pegylated β-Cyclodextrin for Codelivery of Doxorubicin and Cyclopalladated Ferrocene
10.1002/ejic.202101061 ↗33. Determination of the critical micelle concentration of surfactants using fluorescence strategies
10.1039/D2SM01320G ↗34. Sripetthong, S., Eze, F.N., Sajomsang, W., and Ovatlarnporn, C. (2023). Development of pH-Responsive N-benzyl-N-O-succinyl Chitosan Micelles Loaded with a Curcumin Analog (Cyqualone) for Treatment of Colon Cancer. Molecules, 28.
10.3390/molecules28062693 ↗35. Formulation and evaluation of mixed polymeric micelles of quercetin for treatment of breast, ovarian, and multidrug resistant cancers
10.2147/IJN.S153094 ↗37. New chitosan polymer scaffold Schiff bases as potential cytotoxic activity: Synthesis, molecular docking, and physiochemical characterization
10.3389/fchem.2021.796599 ↗41. Preparation and characterization of vanillin-conjugated chitosan-stabilized emulsions via a Schiff-base reaction
10.1007/s10068-023-01277-2 ↗44. Nano-micelles based on hydroxyethyl starch-curcumin conjugates for improved stability, antioxidant and anticancer activity of curcumin
10.1016/j.carbpol.2019.115398 ↗45. Moniruzzaman, M., and Min, T. (2020). Curcumin, curcumin nanoparticles and curcumin nanospheres: A review on their pharmacodynamics based on monogastric farm animal, poultry and fish nutrition. Pharmaceutics, 12.
10.3390/pharmaceutics12050447 ↗46. In vivo efficacy and toxicity of curcumin nanoparticles in breast cancer treatment: A systematic review
10.3389/fonc.2021.612903 ↗47. Quaternization of high molecular weight chitosan for increasing intestinal drug absorption using Caco-2 cells as an in vitro intestinal model
10.1038/s41598-023-34888-0 ↗48. Curcumin encapsulation in self-assembled nanoparticles based on amphiphilic palmitic acid-grafted-quaternized chitosan with enhanced cytotoxic, antimicrobial and antioxidant properties
10.1016/j.ijbiomac.2022.10.064 ↗49. Curcumin and its derivatives in breast cancer: Current developments and potential for the treatment of drug-resistant cancers
10.7243/2052-6199-1-6 ↗50. Potential of amphiphilic graft copolymer α-tocopherol succinate-g-carboxymethyl chitosan in modulating the permeability and anticancer efficacy of tamoxifen
10.1016/j.ejps.2017.02.023 ↗55. Curcumin reverses cisplatin resistance in cisplatin-resistant lung caner cells by inhibiting FA/BRCA pathway
10.1007/s13277-014-2996-4 ↗